VOYA Investment Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Sell |
48,957
-309,578
| -86% | -$8.9M | ﹤0.01% | 1433 |
|
|
2025
Q1 | $12M | Sell |
358,535
-30,685
| -8% | -$1.03M | 0.01% | 680 |
|
|
2024
Q4 | $19.9M | Buy |
389,220
+582
| +0.1% | +$29.8K | 0.02% | 547 |
|
|
2024
Q3 | $19.9M | Buy |
388,638
+151,865
| +64% | +$7.76M | 0.02% | 549 |
|
|
2024
Q2 | $10.6M | Buy |
236,773
+187,515
| +381% | +$8.4M | 0.01% | 739 |
|
|
2024
Q1 | $2.31M | Sell |
49,258
-4,348
| -8% | -$204K | ﹤0.01% | 1302 |
|
|
2023
Q4 | $1.91M | Buy |
53,606
+727
| +1% | +$25.9K | ﹤0.01% | 1385 |
|
|
2023
Q3 | $1.57M | Buy |
52,879
+31,371
| +146% | +$933K | ﹤0.01% | 1435 |
|
|
2023
Q2 | $388K | Buy |
21,508
+902
| +4% | +$16.3K | ﹤0.01% | 2222 |
|
|
2023
Q1 | $331K | Hold |
20,606
| – | – | ﹤0.01% | 2280 |
|
|
2022
Q4 | $377K | Hold |
20,606
| – | – | ﹤0.01% | 2179 |
|
|
2022
Q3 | $405K | Buy |
20,606
+746
| +4% | +$14.7K | ﹤0.01% | 2159 |
|
|
2022
Q2 | $370K | Buy |
19,860
+2,356
| +13% | +$43.9K | ﹤0.01% | 2027 |
|
|
2022
Q1 | $384K | Buy |
17,504
+2,132
| +14% | +$46.8K | ﹤0.01% | 2055 |
|
|
2021
Q4 | $437K | Buy |
15,372
+1,260
| +9% | +$35.8K | ﹤0.01% | 2100 |
|
|
2021
Q3 | $297K | Hold |
14,112
| – | – | ﹤0.01% | 2353 |
|
|
2021
Q2 | $266K | Buy |
14,112
+852
| +6% | +$16.1K | ﹤0.01% | 2433 |
|
|
2021
Q1 | $203K | Buy |
13,260
+748
| +6% | +$11.5K | ﹤0.01% | 2542 |
|
|
2020
Q4 | $177K | Buy |
+12,512
| New | +$177K | ﹤0.01% | 2460 |
|